Zomedica Says Continuing Dialogue With Senior Regulatory Staff At NYSE American Regarding Next Steps To Regaining Compliance With Its Listing Standards
Author: Benzinga Newsdesk | March 13, 2024 04:57pm
Zomedica shares will remain listed on the NYSE American at this time. A Special Meeting of Shareholders was held on February 28, 2024, with the company unable to effect an 80:1 share consolidation corporate action by a required majority of 67.7% votes as set forth by the Company's bylaws. As announced on September 13, 2023, Zomedica received formal notice from the NYSE American that it was not in compliance with continued listing standards
Posted In: ZOM